User:Blent/Seminar 07 fall: Difference between revisions

From OpenWetWare
Jump to navigationJump to search
Line 10: Line 10:
** [http://sa.ylib.com/news/newsshow.asp?FDocNo=438&CL=28 嚴重藥物過敏,可以預防 (科學人 2004 May)]
** [http://sa.ylib.com/news/newsshow.asp?FDocNo=438&CL=28 嚴重藥物過敏,可以預防 (科學人 2004 May)]
** [http://drug.doh.gov.tw/bulletin_cnt.php?PHPSESSID=bg6ksuvuq317fmk4runq4232b6&Pact=bulletin&id=160 我國個人化醫療跨出一大步,讓藥害救濟由事後救濟邁向事前預防 (行政院衛生署藥物資訊網)]
** [http://drug.doh.gov.tw/bulletin_cnt.php?PHPSESSID=bg6ksuvuq317fmk4runq4232b6&Pact=bulletin&id=160 我國個人化醫療跨出一大步,讓藥害救濟由事後救濟邁向事前預防 (行政院衛生署藥物資訊網)]
** [http://www.libertytimes.com.tw/2007/new/sep/18/today-life7.htm 預防抗癲癇藥害 明年起先測基因 (自由時報生活新聞 9/18, 2007)]


* case study: 抗凝血劑之使用劑量評估
* case study: 抗凝血劑之使用劑量評估

Revision as of 20:25, 28 September 2007

Title

  • Toward Personalized Medicine in BMI-based Methodology: A case study of Carbamazepine and challenges in the future

Outlines (Sep 27, 2007)

  • What is personalized medicine
    • personalized
  • case study: 抗凝血劑之使用劑量評估
  • case study: Diabetes and Diagnosis
  • BioBank and Biomarkers discovery
  • General solution: ELSI, Biobank and FDA guide lines

Outlines (Sep 20, 2007)

  • BMI = BI + MI
    • what BMI can do
      • Neuroinformatics (NI)
      • Cancer research (CR)
  • Personalized Medicine (PM)

Background

Materials

Notes